Background and aims Pregnant women have significant morbidity and mortality due to
COVID-19 infection. Pregnancy and diabetes are known risk factors for severe COVID 19 …

Background Gestational diabetes mellitus is one of the most frequent pregnancy
complications with a global prevalence of 13.4% in 2021. Pregnant women with COVID-19 …

Background Among nonpregnant individuals, diabetes mellitus and high body mass index
increase the risk of COVID-19 and its severity. Objective This study aimed to determine …

Objective Diabetes is associated with a more severe SARS-CoV-2 infection phenotype in
non-pregnant individuals. However, there is a limited information about this relationship in …

Objective Diabetes mellitus (DM) has been reported as a risk factor for coronavirus
infectious disease 2019. Whether gestational diabetes mellitus (GDM) also poses an …

There is a lack of information about the maternal-fetal outcomes in patients with gestational
diabetes and concomitant COVID-19; and there is even less information about the outcomes …

Aims We assessed the impact of Covid-19 on gestational diabetes rates in Quebec, the
pandemic epicenter of Canada. Methods We conducted a population-based study of …

In March 2020, the World Health Organization declared a pandemic state in response to the
number of infected and killed by COVID-19. Gestational diabetes (GD) is characterized by …

Background At the beginning of the COVID-19 pandemic, the precise extent of the risks in
pregnancy was uncertain. Because of the known deleterious effects of COVID-19 in patients …

Abstract Aim Individuals with SARS-CoV-2 infection and (pre-existing) diabetes, including
pregnant women, present with more severe morbidity, as compared to non-diabetic subjects …